Skip to main content
Clinical Trials/RBR-6hnmxv
RBR-6hnmxv
Active, not recruiting
未知

Dermatological assessment of primary dermal irritability accumulated and sensitization.

Ipclin - Pesquisa Clínica Integrada0 sitesOctober 10, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Wounds and injuries
Sponsor
Ipclin - Pesquisa Clínica Integrada
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Ipclin - Pesquisa Clínica Integrada

Eligibility Criteria

Inclusion Criteria

  • Full skin in the study region (back); Age 18 to 65 years; Gender; male or female, Participants with phototypes I; II; III and IV (according to Fitzpatrick's classification); Absence of irritation allergy history to the material used in the study; Have signed the Term of Free and Informed Consent (TCLE); Participants who want to participate in the study without financial gain. They will only be reimbursed for transportation and food expenses.

Exclusion Criteria

  • Participants who refuse to participate in the study in question; Skin marks in the experimental area that interfere in the evaluation of possible skin reactions (pigmentation disorders; vascular malformations; scarring; increased hairiness; ephelides and nevus in large quantities; sunburn); Dermatoses (local and disseminated) that could interfere with the results of the study; Pregnant women or infants; History of allergic reactions; irritation or intense discomfort feelings to topical products; for health and medicines; Volunteers with a history of allergy to the material used in the study; History of atopy; History of conditions aggravated or triggered by ultraviolet radiation; Immunodeficiency carriers; Kidney; cardiac or hepatic transplanted patients; Intense sun exposure or tanning session up to 15 days prior to initial evaluation; Forecast of intense sun exposure or session of bron during the course of the study; Forecast of bathing; pool or sauna during the study; Participants practicing aquatic sports;
  • Use of the following topical systemic medicinal products; immunosuppressive; antihistaminic; non\-hormonal anti\-inflammatory drugs; and corticosteroids up to two weeks prior to selection; Treatment with acid vitamin A and or its derivatives via oral or topical use up to 01 month before start of the study; Vaccination prediction during the study or up to 03 weeks before the study; Any condition not mentioned above that in the opinion of the investigator could compromise the evaluation of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials